Artículos por temáticas

Brexpiprazole for Agitation Associated With Dementia Due to Alzheimer's Disease

Lee D, Clark ED, Antonsdottir IM, Porsteinsson AP.

J Am Med Dir Assoc. 2024 Oct;25(10):105173. doi: 10.1016/j.jamda.2024.105173. Epub 2024 Jul 22.

Alzheimer-Type Cerebral Amyloidosis in the Context of HIV Infection: Implications for a Proposed New Treatment Approach

Ellis RJ, Pal S, Achim CL, Sundermann E, Moore DJ, Soontornniyomkij V, Feldman H.

J Neuroimmune Pharmacol. 2024 Jun 3;19(1):27. doi: 10.1007/s11481-024-10126-w.

Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep Disorders

Carpi M, Mercuri NB, Liguori C.

Drugs. 2024 Nov;84(11):1365-1378. doi: 10.1007/s40265-024-02096-3. Epub 2024 Oct 4.

Therapeutic Effects of Plant Anthocyanin against Alzheimer's Disease and Modulate Gut Health, Short-Chain Fatty Acids

Bayazid AB, Lim BO.

Nutrients. 2024 May 21;16(11):1554. doi: 10.3390/nu16111554.

A review on synthetic inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the treatment of Alzheimer's disease (AD)

Gehlot P, Pathak R, Kumar S, Choudhary NK, Vyas VK.

Bioorg Med Chem. 2024 Nov 1;113:117925. doi: 10.1016/j.bmc.2024.117925. Epub 2024 Sep 14.

Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer's, Cancer and Cardiovascular Disease

Coppinger C, Pomales B, Movahed MR, Marefat M, Hashemzadeh M.

Curr Rev Clin Exp Pharmacol. 2024;19(4):312-326. doi: 10.2174/0127724328250471231222094648.

The role and mechanism of dapagliflozin in Alzheimer disease: A review

Chen P, Liang L, Dai Y, Hui S.

Medicine (Baltimore). 2024 Sep 27;103(39):e39687. doi: 10.1097/MD.0000000000039687.

[Ginkgolide B: mechanisms of neurobiological effects, prospects for use in the therapy of Alzheimer's disease]

Berezutsky MA, Durnova NA, Andronova TA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(4):22-27. doi: 10.17116/jnevro202412404122.

Interpretation of 10 years of Alzheimer's disease genetic findings in the perspective of statistical heterogeneity

Gao S, Wang T, Han Z, Hu Y, Zhu P, Xue Y, Huang C, Chen Y, Liu G.

Brief Bioinform. 2024 Mar 27;25(3):bbae140. doi: 10.1093/bib/bbae140.

Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers

Bisi N, Pinzi L, Rastelli G, Tonali N.

Molecules. 2024 Feb 4;29(3):722. doi: 10.3390/molecules29030722.

An insight into the concept of neuroinflammation and neurodegeneration in Alzheimer's disease: targeting molecular approach Nrf2, NF-κB, and CREB

Bhardwaj S, Grewal AK, Singh S, Dhankar V, Jindal A.

Inflammopharmacology. 2024 Oct;32(5):2943-2960. doi: 10.1007/s10787-024-01502-2. Epub 2024 Jun 29.

Dysregulation of Noradrenergic Activity: Its Role in Conceptualizing and Treating Major Depressive Disorder, Schizophrenia, Agitation in Alzheimer's Disease, and Posttraumatic Stress Disorder

Jain R, Chepke C, Davis LL, McIntyre RS, Raskind MA.

J Clin Psychiatry. 2024 Nov 8;85(4):plunaro2417ah. doi: 10.4088/JCP.plunaro2417ah.

Association between treatment with sacubitril/valsartan and the risk of Alzheimer's disease: a clinical update

Garnier-Crussard A.

Alzheimers Res Ther. 2024 Aug 1;16(1):177. doi: 10.1186/s13195-024-01547-z.

The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson's Disease: A Promising Therapeutic Approach

So YJ, Lee JU, Yang GS, Yang G, Kim SW, Lee JH, Kim JU.

Int J Mol Sci. 2024 Jan 15;25(2):1071. doi: 10.3390/ijms25021071.

Unlocking choline's potential in Alzheimer's disease: A narrative review exploring the neuroprotective and neurotrophic role of phosphatidylcholine and assessing its impact on memory and learning

Conway T, Seidler K, Barrow M.

Clin Nutr ESPEN. 2024 Dec;64:177-195. doi: 10.1016/j.clnesp.2024.09.024. Epub 2024 Sep 30.